Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint

British Journal of Oral and Maxillofacial Surgery

Volumn 48, Issue 4, 2010, Pages 281-284

  Fu, Kai Yuan ^a   Chen, Hui Min ^b   Sun, Zhi Peng ^a   Zhang, Zhen Kang ^b   Ma, Xu Chen ^a  

^a PEKING UNIVERSITY   (China)

^b Center for TMD and Orofacial Pain   (China)

Author keywords

Botulinum toxin type A; Dislocation; Lateral pterygoid muscle; Temporomandibular joint

Indexed keywords

BOTULINUM TOXIN A;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; BRAIN ATROPHY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPRESSION FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; EXTRACORPOREAL CIRCULATION; FEMALE; FEMUR NECK FRACTURE; HEMIPLEGIA; HUMAN; JOINT DISLOCATION; MALE; MASTICATORY MUSCLE; OSTEOPOROSIS; SKIN SURFACE; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; CHRONIC DISEASE; DISLOCATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRAMUSCULAR; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PTERYGOID MUSCLES; RECURRENCE; TEMPOROMANDIBULAR JOINT DISORDERS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77952108108     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2009.07.014     Document Type: Article

References (15)

1. Undt G., Kermer C., Piehslinger E., and Rasse M. Treatment of recurrent mandibular dislocation. Part I. Leclerc blocking procedure. Int J Oral Maxillofac Surg 26 (1997) 92-97
2. Hale R.H. Treatment of recurrent dislocation of the mandible: review of literature and report of cases. J Oral Surg 30 (1972) 527-530
3. Ugboko V.I., Oginni F.O., Ajike S.O., Olasoji H.O., and Adebayo E.T. A survey of temporomandibular joint dislocation: aetiology, demographics, risk factors and management in 96 Nigerian cases. Int J Oral Maxillofac Surg 34 (2005) 499-502
4. Daelen B., Thorwirth V., and Koch A. Neurogenic temporomandibular joint dislocation. Definition and therapy with botulinum toxin. Nervenarzt 68 (1997) 346-350 (in German)
5. Sayama S., Fujimoto K., Shizuma N., and Nakano I. Habitual mandibular dislocation in two patients with Parkinson's disease. Rinsho Shinkeigaku 39 (1999) 849-851 (in Japanese)
6. Merrill R.G. Habitual subluxation and recurrent dislocation in a patient with Parkinson's disease: report of case. J Oral Surg 26 (1968) 473-477
7. Aquilina P., Vickers R., and McKellar G. Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A. Br J Oral Maxillofac Surg 42 (2004) 272-273
8. Shorey C.W., and Campbell J.H. Dislocation of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 (2000) 662-668
9. McKelvey L.E. Sclerosing solution in the treatment of chronic subluxation of the temporomandibular joint. J Oral Surg (Chic) 8 (1950) 225-236
10. Leopard P.J. Surgery of the non-ankylosed temporomandibular joint. Br J Oral Maxillofac Surg 25 (1987) 138-148
11. Moore A.P., and Wood G.D. Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 183 (1997) 415-417
12. Martínez-Pérez D., and García Ruiz-Espiga P. Recurrent temporomandibular joint dislocation treated with botulinum toxin: report of 3 cases. J Oral Maxillofac Surg 62 (2004) 244-246
13. Yoshida K., and Iizuka T. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia. Cranio 24 (2006) 217-222
14. de Paiva A., Meunier F.A., Molgó J., Aoki K.R., and Dolly J.O. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96 (1999) 3200-3205
15. Ziegler C.M., Haag C., and Mühling J. Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Investig 7 (2003) 52-55